Celeste Love

Celeste Love has extensive experience in the field of clinical operations. Celeste currently holds the position of Senior Director Clinical Operations at Corcept Therapeutics. Prior to this, Celeste worked as the Director Clinical Operations at Corcept Therapeutics from 2018 to 2021. Before joining Corcept Therapeutics, Celeste worked at Exelixis as an Associate Director, Clinical Operations, where they successfully managed a global phase III study in Hepatocellular Carcinoma (HCC) that resulted in positive data and publication in the New England Journal of Medicine. Celeste also managed an FDA phase IV commitment in Medullary thyroid cancer (MTC) during their tenure at Exelixis. Celeste gained further experience in clinical study management as a Global Clinical Study Manager - Consultant at Amgen. Prior to Amgen, Celeste held the position of Clinical Program Manager at both Nektar Therapeutics and InterMune. Celeste started their career as a Clinical Trial Manager at Genentech in 2000.

Celeste Love holds a Master's degree from the University of San Francisco, although the specific field of study is not provided. Celeste also has a Bachelor of Science degree in Health Services/Allied Health/Health Sciences, General from California State University - East Bay. Furthermore, they completed their high school education at Sacred Heart Cathedral Prep in San Francisco, with a focus on general studies.